References
Eichelbaum M, Reetz K-P, Schmidt EK, Zekorn C (1986) The genetic polymorphism of sparteine metabolism. Xenobiotica 16: 465–481
Ishizaki T, Eichelbaum M, Horai Y, Hashimoto K, Chiba K, Dengler HJ (1987) Evidence for polymorphic oxidation of sparteine in Japanese subjects. Br J Clin Pharmacol 23: 482–485
Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol 16: 183–187
Evans DAP, Harmer D, Downham EY, Whibley EJ, Idle JR, Ritchie J, Smith RL (1983) The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet 20: 321–329
Brøsen K, Otton SV, Gram LF (1986) Sparteine oxidation polymorphism: A family study. Br J Clin Pharmacol 21: 661–667
Eichelbaum M, Bertilsson L, Säwe J, Zekorn C (1982) Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities. Clin Pharmacol Ther 31: 184–186
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiba, K., Kato, J., Hashimoto, K. et al. Apparent Mendelian recessive inheritance of sparteine metabolism in an extended Japanese family. Eur J Clin Pharmacol 34, 661–662 (1988). https://doi.org/10.1007/BF00615236
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00615236